Aprea Therapeutics
-
Two Life Sciences Companies with Doylestown Connections Raise $119M
Aprea Therapeutics and Pinnacle Medicines, two life sciences companies with connections to Doylestown, have raised a combined $119 million from investors, writes John George for the Philadelphia Business Journal. …
-
Doylestown’s Aprea Therapeutics Names Industry Veteran as Chief Medical Advisor
Doylestown-based Aprea Therapeutics has named Eugene Kennedy, MD, as chief medical advisor, adding a seasoned leader in oncology drug development to its executive team. Aprea…
-
Doylestown Cancer Pharma Moves Closer to Starting Clinical Testing on Its 3rd Experimental Cancer Treatment
Doylestown-based Aprea Therapeutics is moving closer to entering clinical testing with its third potential experimental cancer treatment, writes John George for the Philadelphia Business Journal.…
-
Aprea Therapeutics Secures Up to $34 Million in Groundbreaking Financing Deal
Doylestown-based Aprea Therapeutics, a leader in precision oncology, has successfully secured a financing deal anticipated to bring in up to $34 million in proceeds, writes…
-
Biotechnology Center in Doylestown Seeks State Funding to Continue Support for Life Science Start-Ups
A Bucks County biotechnology center pilot program is seeking to bring life sciences companies to the Keystone State, writes John George for the Philadelphia Business…
-
Doylestown Biopharmaceutical Company Reports Second Quarter Finanical Results
Aprea Therapeutics, Inc., headquarted at 3805 Old Easton Road in Doylestown, has reported their financial results for the second fiscal quarter of 2023. Staff writers…
Founding Partners
Advertisement
Affiliate Partners
